We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
-10.3%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.85B
AUM Growth
-$949M
Cap. Flow
-$393M
Cap. Flow %
-10.22%
Top 10 Hldgs %
10.07%
Holding
2,323
New
652
Increased
471
Reduced
539
Closed
577

Sector Composition

Rank Sector Weight
1 Technology 15.44%
2 Consumer Discretionary 14.53%
3 Healthcare 13.43%
4 Industrials 13.16%
5 Financials 12.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNI icon
651
HNI Corp
HNI
$3.59B
$1.47M 0.04%
41,424
-25,226
-38% -$957K
BPOP icon
652
Popular Inc
BPOP
$11.1B
$1.47M 0.04%
+31,070
New +$1.6M
CLH icon
653
Clean Harbors
CLH
$16.3B
$1.47M 0.04%
+29,712
New +$1.85M
AIN icon
654
Albany International
AIN
$1.78B
$1.46M 0.04%
23,439
-24,761
-51% -$1.73M
CARG icon
655
CarGurus
CARG
$3.47B
$1.46M 0.04%
43,381
+23,756
+121% +$952K
PNNT
656
Pennant Park Investment Corp
PNNT
$241M
$1.46M 0.04%
228,699
+104,480
+84% +$743K
LE icon
657
Lands' End
LE
$403M
$1.46M 0.04%
102,475
+88,304
+623% +$1.43M
CMP icon
658
Compass Minerals
CMP
$1.15B
$1.45M 0.04%
+34,850
New +$1.84M
ALTR
659
DELISTED
Altair Engineering Inc
ALTR
$1.45M 0.04%
52,640
-34,452
-40% -$1.14M
DF
660
DELISTED
Dean Foods Company
DF
$1.45M 0.04%
380,863
-40,074
-10% -$242K
ITGR icon
661
Integer Holdings
ITGR
$4.26B
$1.45M 0.04%
+19,001
New +$1.52M
LRMR icon
662
Larimar Therapeutics
LRMR
$432M
$1.45M 0.04%
24,369
+2,503
+11% +$247K
VNDA icon
663
Vanda Pharmaceuticals
VNDA
$302M
$1.45M 0.04%
55,298
-55,064
-50% -$1.29M
CMCO icon
664
Columbus McKinnon
CMCO
$584M
$1.44M 0.04%
47,848
-17,122
-26% -$581K
GLPI icon
665
Gaming and Leisure Properties
GLPI
$12.8B
$1.44M 0.04%
44,639
-32,286
-42% -$1.09M
AMPY icon
666
Amplify Energy
AMPY
$166M
$1.44M 0.04%
191,273
+150,736
+372% +$1.2M
TWTR
667
DELISTED
Twitter, Inc.
TWTR
$1.44M 0.04%
+49,931
New +$1.57M
DOX icon
668
Amdocs
DOX
$6.22B
$1.43M 0.04%
+24,425
New +$1.53M
CNR
669
Core Natural Resources Inc
CNR
$4.45B
$1.43M 0.04%
45,024
-32,018
-42% -$1.18M
ALXN
670
DELISTED
Alexion Pharmaceuticals
ALXN
$1.43M 0.04%
+14,660
New +$1.73M
SMPL icon
671
Simply Good Foods
SMPL
$982M
$1.43M 0.04%
75,443
-95,455
-56% -$1.8M
AVB icon
672
AvalonBay Communities
AVB
$26.8B
$1.42M 0.04%
8,171
-13,427
-62% -$2.43M
CVGI icon
673
Commercial Vehicle Group
CVGI
$147M
$1.42M 0.04%
249,065
+133,215
+115% +$923K
GSBC icon
674
Great Southern Bancorp
GSBC
$878M
$1.42M 0.04%
30,856
+15,278
+98% +$798K
LOGM
675
DELISTED
LogMein, Inc.
LOGM
$1.42M 0.04%
+17,380
New +$1.47M

Similar funds

Oxford Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Oxford Asset Management held 2,323 positions worth $3.85B, down 20% from $4.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Oxford Asset Management withdrew a net $393M in Q4 2018, closing 577 positions and reducing 539 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $105M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Oxford Asset Management opened a new position in Athenahealth, Inc. worth $69.9M.

  • Oxford Asset Management's largest Q4 2018 buy was Athenahealth, Inc.: 530,000 shares worth $69.9M.
  • Oxford Asset Management added most to Integrated Device Technology I in Q4 2018, an estimated $34.6M increase.
  • Oxford Asset Management's biggest Q4 2018 reduction was GE Aerospace, cutting an estimated $18.1M.
  • Oxford Asset Management fully exited Envision Healthcare Holdings Inc in Q4 2018, selling an estimated $105M.
  • Oxford Asset Management's ten largest holdings make up 10% of its $3.85B portfolio in Q4 2018.
  • Oxford Asset Management opened 652 new positions and closed 577 in Q4 2018.
  • Oxford Asset Management's portfolio value fell 20% quarter-over-quarter to $3.85B.

Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.